Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach. (Record no. 26739813)

MARC details
000 -LEADER
fixed length control field 01510 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517132320.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201704s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-6535
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/cpt.558
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Arwood, M J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170425
245 00 - TITLE STATEMENT
Title Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical pharmacology and therapeutics
Date of publication, distribution, etc. May 2017
300 ## - PHYSICAL DESCRIPTION
Extent 675-683 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Algorithms
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Alleles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anticoagulants
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytochrome P-450 CYP2C9
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Endpoint Determination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacogenetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vitamin K Epoxide Reductases
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Warfarin
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Deng, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Drozda, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pugach, O
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nutescu, E A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schmidt, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duarte, J D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cavallari, L H
773 0# - HOST ITEM ENTRY
Title Clinical pharmacology and therapeutics
Related parts vol. 101
-- no. 5
-- p. 675-683
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/cpt.558">https://doi.org/10.1002/cpt.558</a>
Public note Available from publisher's website

No items available.